// App-Quantinova.ai

9624 : Clinical risk prediction in anthracycline cardiotoxicity.

Researchers

Presenter

  • Bonnie Ky

Principal Investigators

  • Carla L. Warneke

  • Daniel John Lenihan

  • Jakub Svoboda

  • Stephen J. Schuster

  • Nishitha M. Reddy

  • Sunil M. Patel

  • Alyssa G. Rieber

  • Marcella M Johnson

  • Mark G. Campbell

  • Chilakamarri Yeshwant

  • Paul T. Adams

  • Ron Krone

  • Joseph R. Carver

  • Sunita Nasta

  • Michael Fisch

  • Puneet S. Cheema

  • Dennis Frederic Moore

Medical Centers

  • Michigan Cancer Research Consortium NCORP, Ypsilanti, MI

  • Cancer Ctr of Kansas, Wichita, KS

  • University of Pennsylvania, Philadelphia, PA

  • Central Illinois CCOP, Springfield, IL

  • Vanderbilt University Medical Center, Nashville, TN

  • Washington University in St. Louis, St. Louis, MOThe University of Texas MD Anderson Cancer Center, Houston, TXHealtheast Care, St. Paul, MN

  • The University of Texas MD Anderson Cancer Center, Regional Care Center Katy, Katy, TX

  • Cancer Hem Ctr of Western Michigan, Grand Rapids, MI

  • Vanderbilt University, Nashville, TN

  • Hospital of the University of Pennsylvania, Philadelphia, PA

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left ventricular dysfunction

  • Acute Coronary Syndromes

  • Cardiotoxicity

  • Congestive heart failure

  • Arrhythmia

Biomarkers

  • B-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved